The Addition of Bleomycin and Dose-Escalated Ifosfamide to the Combination of Cisplatin Plus Ifosfamide Does Not Improve Survival in Advanced or Recurrent Cervical Carcinoma-Reference-Cited by-同舟云学术

The Addition of Bleomycin and Dose-Escalated Ifosfamide to the Combination of Cisplatin Plus Ifosfamide Does Not Improve Survival in Advanced or Recurrent Cervical Carcinoma

Published:1997 Issue:3 Volume:20 Page:315-318
ISSN:0277-3732
Container-title:American Journal of Clinical Oncology
language:en
Short-container-title:American Journal of Clinical Oncology

Author:

Hempling Ronald E.,Eltabbakh Gamal H.,Piver M. Steven,Recio Fernando O.,O'Neill Catherine P.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference13 articles.

1. Cis-platinum in treatment of advanced or recurrent squamous cell carcinoma of the cervix: A phase ii study of the gynecologic oncology group

2. Weekly cisplatin induction chemotherapy in the treatment of recurrent cervical carcinoma

3. Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: a Gynecologic Oncology Group study.

4. A randomized comparison of a rapid versus prolonged (24 hr) infusion of cisplatin in therapy of squamous cell carcinoma of the uterine cervix: A gynecologic oncology group study

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase II study of tirapazamine plus cisplatin in patients with advanced or recurrent cervical cancer;International Journal of Gynecological Cancer;2006-05

2. Prognostic factors and survival in patients with metastatic or recurrent carcinoma of the uterine cervix;International Journal of Gynecological Cancer;2003-07

3. Neoadjuvant Chemotherapy With Ifosfamide, Cisplatin, and Vinorelbine in Advanced Squamous Cell Carcinoma of the Cervix;American Journal of Clinical Oncology;2000-10

4. Phase II Study of Irinotecan and Cisplatin as First-Line Chemotherapy in Advanced or Recurrent Cervical Cancer;Oncology;2000